Bladder Tumors (TURBT) Coding and Reimbursement

Overview

Bladder Tumors (TURBT)
Coding & Documentation Overview

Transurethral resection of bladder tumor is coded by the size of the largest tumor resected52234 small (0.5–2.0 cm), 52235 medium (2.0–5.0 cm), 52240 large (>5.0 cm) — and only one TURBT code is reported per session no matter how many tumors are treated. Minor lesions have their own family (52224 fulguration of lesion(s) ≤0.5 cm; 52214 fulguration of bleeding sites/minor lesions). All of these carry 0-day globals, and the op note's tumor size, number, and location language decides the code — and survives the audit.

Related pages: Bladder Cancer: High-Risk NMIBC · NMIBC: Recurrent-LG-Intermediate Risk · Upper Tract Urothelial Cancer.

Most common services
  • TURBT — small/medium/large (52234/52235/52240)
  • Cysto with fulguration of minor lesions (52214/52224)
  • Cysto with biopsy (52204)
  • Same-day postoperative intravesical chemotherapy instillation
Documentation drivers (prevent denials)
  • Tumor size: measured size of the largest tumor, stated in cm
  • Number and location: each tumor described
  • Completeness: resection vs fulguration vs biopsy of each lesion
  • Hematuria coding: active hematuria vs history-of on workup cystos
Coding patterns (high-level)
  • One TURBT code per session, selected by largest tumor size
  • Post-op instillation: 51720 + drug (e.g., J9280 mitomycin) per payer bundling rules [VERIFY: same-session edits]
  • ICD-10: C67.- by site; D41.4 uncertain behavior (pathology-confirmed); R31.0 gross hematuria on workup
Common denial causes
  • Two TURBT codes billed for one session
  • Size not documented — code indefensible on review
  • History-of hematuria code where the active code is needed
  • Biopsy billed separately when included in the resection of the same lesion

Top Questions (quick answers)

Multiple tumors resected — can I bill more than one TURBT code?

No. Report one TURBT code per session, selected by the size of the largest tumor resected. Multiple tumors support the documentation, not extra codes.

Which code for a 2.5 cm tumor?

52235 (medium, 2.0–5.0 cm). Under 0.5 cm is fulguration territory (52224); 0.5–2.0 cm is 52234; over 5.0 cm is 52240.

What if only part of the tumor could be resected?

Code the session by the size of the tumor addressed and document the extent and the reason resection was incomplete; a planned restaging/completion TURBT is a new session with its own code [VERIFY: payer guidance on staged resections].

Is the same-day mitomycin instillation separately billable?

Post-TURBT single-dose chemotherapy instillation is commonly performed; whether 51720 is separately payable with the TURBT depends on current NCCI edits and setting — verify before adding it, and always capture the drug [VERIFY: NCCI].

What diagnosis on the hematuria-workup cysto?

Code the active finding (R31.0 gross hematuria) — not "history of hematuria" — on the claim for the diagnostic cysto, even if bleeding has paused by the day of the scope; update to the neoplasm code once pathology confirms.

TURBT vs fulguration vs biopsy — how do the families divide?
Resection of tumor 0.5 cm or larger → the TURBT family by size. Destruction/fulguration of small lesion(s) ≤0.5 cm (with or without biopsy) → 52224. Fulguration of bleeding sites or minor lesions with no measurable resection → 52214. Biopsy alone without treatment → 52204. The op note's verbs and measurements pick the code.

Can 52204 be billed with a TURBT?
Not for the same lesion — biopsy of the resected tumor is included. A separately documented biopsy of a distinct site may be reportable subject to NCCI; document the separate site explicitly [VERIFY: NCCI].

Why does the 0-day global matter?
Unlike major surgery, follow-up visits after TURBT are separately billable E/M services — and the surveillance cystoscopy schedule that follows is each separately reportable. Do not suppress post-TURBT visits out of 90-day-global habit.

Where does the pathway go after pathology?
Risk stratification routes the patient to the intermediate-risk or high-risk NMIBC pages for intravesical therapy coding, or out of NMIBC entirely if muscle-invasive.

Facility-facing: where do TURBTs run?
TURBT is ASC/HOPD territory (5223452240 carry facility-only practice expense); the minor fulguration and biopsy codes are office-capable. Confirm status indicators per setting [VERIFY: SI/APC].

Links to Product-Specific Coding and Reimbursement Information

Coming Soon